Project Details
Short title | Phase 1/2, open-label, randomized study of the safety, efficacy and pharmacokinetics of Letrozole plus PD 0332991 (oral CDK 4/6 inhibitor) and Letrozole single agent for the first-line treatment of ER Positive, HER2 negative ADVANCED Breast |
---|---|
Status | Finished |
Effective start/end date | 1/01/12 → 31/12/14 |
Funding
- Sandwell & West Birmingham Hospitals